‘All Kratom Is Unsafe’: Senators Want DEA to Reconsider Scheduling 

By Pat Anson

Eight U.S. Senators are making a last-minute plea to the Trump Administration to scrap plans to classify 7-hydroxymitragynine (7-OH) and other concentrated kratom alkaloids as illegal Schedule One controlled substances. 

In a letter to the heads of the DEA and FDA, Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) and seven of his Republican colleagues claim that “all Kratom is unsafe” and called on the agencies to reconsider their October scheduling order – which could take effect any day.

That order will essentially ban most forms of 7-OH and synthetic kratom derived products – while keeping natural leaf kratom legal. Grassley and his colleagues say that would be a mistake.

“Kratom is an opioid. Interested parties’ word play often involves differentiating between ‘natural’ and ‘synthetic’ products. Surely artificially enhanced Kratom products are often more dangerous, but that does not mean that so-called ‘natural’ ones are safe. Nor does marketing a product as ‘natural’ make it a dietary supplement or recognized as safe,” the letter states.

In a previous letter, Grassley and two other senators called on the Trump Administration to “consider scheduling the entire kratom plant.” The new letter doesn’t go that far, but shows that Grassley’s views on kratom are gaining some traction — and signatures — in Congress.

Sens. Susan Collins, Rick Scott, Mike Crapo, Bill Cassidy, Jerry Moran, Shelley Moore Capito and James Risch co-signed the new letter.

The DEA’s October scheduling order is a revised version of a previous order that would have banned 7-OH and all other synthetic forms of kratom. The new order is a bit more lenient, allowing for trace amounts of 7-OH and the alkaloid mitragynine pseudoindoxyl (MP) in tablets, gummies and liquid shots, provided they are limited to 1 mg per serving.    

Grassley and his colleagues say the new scheduling order is too lenient and would allow addictive products on the market.

“Kratom is a drug in any form with addictive properties, and we believe this combined threshold level for 7-OH and MP set by DEA is inappropriately high and unsound. MP is a semi-synthetic opioid that is more potent than morphine. To date whether MP is naturally occurring in the plant is unclear. If the Administration’s goal is to remove all unsafe products from the shelves, particularly synthetic or enhanced kratom products, this order misses the mark,” the letter states.

The senators want the FDA to explain why it supports the new scheduling order and for the DEA to revert back to its original one. They asked for a reply by November 30.

The DEA’s amended order is largely in response to a lawsuit by the American Kratom Association (AKA), which represents natural leaf kratom vendors who are losing market share to 7-OH and other synthetic manufacturers.

The AKA supported the scheduling of 7-OH, but wanted a “carve out” for mitragynine pseudoindoxyl, which the DEA banned just three months ago. The AKA dismissed its lawsuit once the DEA agreed to the carve out.

At this late date, it’s unclear if the senators’ letter could lead to a delay or further changes in the DEA’s scheduling order.  

Kratom leaves have been used for centuries in Southeast Asia as a natural stimulant and pain reliever. Their active ingredients – 7-OH and dozens of alkaloids – occur naturally in kratom in trace amounts. But in recent years manufacturers have found ways to concentrate the alkaloids in new products – essentially turning a mild pain reliever into a potent product with opioid-like effects. 

Federal efforts to schedule kratom under the Controlled Substances Act have been fraught with problems and poor science for over a decade. 

In 2016, the DEA tried to schedule kratom as an illegal drug, but withdrew the proposal after a public outcry. A top federal health official later admitted the scheduling request was based on “embarrassingly poor evidence & data” from the FDA and could result in a “substantial risk to public health” if kratom leaf were made illegal.

A public policy think tank recently warned that banning leaf kratom, 7-OH, and other kratom-derived synthetics could have unintended and harmful consequences. Consumers who are dependent on those products could go into withdrawal or turn to illicit drugs on the black market.